Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ future pipeline to focus more on complex generics—drugs that have ...

Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click for my updated look at VIR ...

The US FDA notes that China ranks third among ... despite this adding time and expense to the drug development process. A project to use federal databases to identify the "root causes of autism ...

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...

Operator: Greetings and welcome to the Amphastar Pharmaceuticals First Quarter Earnings Call. At this time, all participants ...

The U.S. Food and Drug Administration (FDA) on Thursday announced an expedited plan to implement artificial intelligence (AI) ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The FDA is looking into how AI could help with final drug approvals and improve internal tasks like checking whether an ...

The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...

The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...

A new report from Wired reveals the supposed ongoing discussions between the FDA and OpenAI that seeks to leverage AI for ...